SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cytokine1 who wrote (7248)12/4/1999 3:52:00 PM
From: Vector1  Read Replies (3) of 9719
 
CYTO,
ADD 2000 shares of CLTR on Monday at the open at 17.50 or better. We could see a gap openning.
HUGE NEWS. The updated Bex plus Fludarabine results exceeded my expectations. 100% response and 71% complete response at 6 months. Only one HAMA response. Multi center studies to begin next year. If the multi center studies confirm these results we could be looking at the standard of care in first line NHL treatment. That would make CLTR a 10-20 bagger from where we are now. Of course they have to get the damm BLA filing accepted. I am so excited I am going out of my mind. Does anyone else have a different reaction. Someone, Rick, Biowa, PB, Peter, David K., Gordon, RW Reeves, Bob L, bring me back to earth.

V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News